Lexeo Therapeutics, Inc. (LXEO) SEC Filings — 2024
28 SEC filings for Lexeo Therapeutics, Inc. (LXEO) in 2024.
Filings
- Lexeo Therapeutics Files 8-K for Director/Officer Changes — 8-K · Dec 19, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexeo Therapeutics Files 8-K — 8-K · Nov 13, 2024
- Lexeo Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 12, 2024
- Lexeo Therapeutics, Inc. 8-K Filing — 8-K · Oct 30, 2024
- Lexeo Therapeutics Files 8-K — 8-K · Oct 9, 2024
- Lexeo Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Aug 9, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Aug 5, 2024
- Lexeo Therapeutics Files 8-K — 8-K · Jul 15, 2024
- Lexeo Therapeutics Appoints New CMO, Director — 8-K · Jul 8, 2024
- Lexeo Therapeutics Files 8-K on Shareholder Votes — 8-K · Jun 28, 2024
- Lexeo Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Lexeo Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Lexeo Therapeutics Files 8-K: Material Definitive Agreement — 8-K · Apr 22, 2024
- Lexeo Therapeutics Appoints New Directors, Adjusts Executive Pay — 8-K · Apr 22, 2024
- Lexeo Therapeutics Files 8-K — 8-K · Apr 16, 2024
- Lexeo Therapeutics Files S-1 for Potential IPO — S-1 · Apr 9, 2024
- Lexeo Therapeutics Files 8-K: Agreements, Financials, Equity Sales — 8-K · Mar 11, 2024
- Lexeo Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Lexeo Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Lexeo Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Lexeo Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Lexeo Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 13, 2024
- Lexeo Therapeutics Confirms 'Emerging Growth Company' Status — 8-K · Feb 5, 2024